Inflation, high rates challenge Corby’s outlook
But dividend now yielding 6.5% is substantial and consistent
Category: Featured Post
Inflation, weak cannabis market hurt Scotts Miracle-Gro
With $3.9 billion in annual sales Scotts Miracle-Gro Co. (NYSE: SMG) is one of the world’s largest marketers of brandedContinue Reading
Drugmakers see booming demand for weight-loss drugs
Strong demand for Wegovy, Ozempic just scratching surface, says CEO of Novo Nordisk
EV sales slump as consumers take stock
More models mean more choice and a mismatch between supply and demand.
The perils of space stocks and out-of-this world investing
Space tourism has no real business for now. Satellites and components are a better bet.
Nutrien sags on weak fertiliser prices
Nutrien Corp. (TSX, NYSE: NTR) is the world’s largest producer of agricultural fertilizers, including nitrogen and phosphates which it sellsContinue Reading
AI tailwinds drive Nvidia higher
CEO Jensen Huang says new computing era has begun.
Medtech stocks rebound as hospital pressures ease
Shipping costs and chip shortages have eased as demand for elective surgeries has recovered
Weight loss drugs Ozempic, Wegovy may be right for investors
Celebrity endorsements helping build market potential, analysts say
Medtronic stumbles amid medtech recovery
Slowing growth in core businesses, plus recalls and bribery allegation have worried investors
Adam Mayers 
You must be logged in to post a comment.